http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0363836-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 1989-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69145ccfaa7accefc846e04c82a6fb01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ec5fbe9606be5a4978aa891fb29492 |
publicationDate | 1990-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0363836-A2 |
titleOfInvention | Use of homopiperazines in the preparation of a medicament for preventing or treating organ rejection reactions |
abstract | It is described that compounds of the formula I in which R¹ is a hydrogen atom, a straight-chain or branched (C₁-C₆) alkoxycarbonyl group, preferably CH₃OCO, C₂H₅OCO or tert.-C₄-₉OCO, or the benzyloxycarbonyl group, which can be substituted in the phenyl part, means, and their physiologically acceptable salts can be used in the manufacture of a medicament for humans and animals for the prevention and treatment of organ rejection reactions. |
priorityDate | 1988-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.